ARS
Latest Information Update: 04 Sep 2006
Price :
$35 *
At a glance
- Drugs Irbesartan (Primary)
- Indications Stroke
- Focus Pharmacodynamics
- Acronyms ARS
- Sponsors Sanofi-Synthelabo
- 04 Sep 2006 The expected completion date for this trial is now 1 Feb 2007.
- 04 Sep 2006 New trial record.